Godrej Agrovet achieved a record consolidated revenue of over ₹10,000 crore and highest-ever profitability in FY26. The company declared a 110% final dividend and went live with SAP S/4HANA Wave 1.
Godrej Agrovet Crosses ₹10,000 Crore Revenue Milestone with Record Profitability
Godrej Agrovet has achieved a significant milestone, surpassing ₹10,000 crore in consolidated revenue for the financial year 2025-26, alongside reporting its highest-ever profitability. Consolidated total income rose by 9.7% to ₹10,339 crore from ₹9,426 crore in the previous fiscal.
Reader Takeaway: Record revenue and profit growth driven by key segments, but watch weather and geopolitical risks.
What Just Happened
Godrej Agrovet reported a consolidated total income of ₹10,339 crore for FY 2025-26, a 9.7% increase year-on-year. The company also achieved its highest-ever profitability, with consolidated Profit After Tax (PAT) growing 13.7% to ₹439 crore from ₹386 crore in FY 2024-25. Consolidated EBITDA saw a 10.8% rise to ₹936 crore.
Additionally, the company's shareholders approved a final dividend of 110%, amounting to ₹11 per share. The successful go-live of SAP S/4HANA Wave 1 marks a significant step in its digital transformation strategy.
Why This Matters
Crossing the ₹10,000 crore revenue mark signifies substantial operational scale and market penetration for Godrej Agrovet. The record profitability underscores improved efficiency and margin management. The dividend payout rewards shareholders, while the digital transformation initiative aims to enhance future operational capabilities and customer experience.
The Backstory
In the previous fiscal year (FY 2024-25), Godrej Agrovet had reported consolidated total income of ₹9,426 crore and PAT of ₹386 crore. The company has been focusing on strengthening its core businesses and optimizing its balance sheet. Net working capital days were reduced to 25 in FY 2025-26 from 39 in the prior year, and ROCE improved to 20% from 16%.
What Changes Now
The company's strong performance in its Animal Nutrition and Oil Palm segments is expected to continue driving growth. The EBITDA break-even achieved by Astec LifeSciences is a positive sign for its turnaround. Management has also secured re-appointment for key directors and chairperson.
Risks to Watch
Adverse weather conditions, particularly a below-normal monsoon forecast for 2026, could impact kharif sowing and agricultural input demand. Macroeconomic uncertainties, including geopolitical tensions and trade policy shifts, pose potential risks to input costs and overall market demand.
Peer Comparison
While specific peer financials for the same period are not detailed in the filing, Godrej Agrovet's performance in its key segments like Animal Nutrition and Oil Palm is noteworthy. The Animal Nutrition segment grew volumes by 12%, supported by strong brand equity. The Oil Palm segment saw a 68% profit jump due to higher arrivals and extraction ratios.
Context Metrics (Time-bound)
- Consolidated Total Income: ₹10,339 crore (FY 2025-26) vs. ₹9,426 crore (FY 2024-25) - +9.7% growth.
- Consolidated PAT: ₹439 crore (FY 2025-26) vs. ₹386 crore (FY 2024-25) - +13.7% growth.
- Net Working Capital Days: 25 days (FY 2025-26) vs. 39 days (FY 2024-25).
- ROCE: 20% (FY 2025-26) vs. 16% (FY 2024-25).
- Final Dividend: 110% (₹11 per share).
What to Track Next
Investors will be keen to monitor the performance of the Crop Care and Dairy segments, which faced headwinds. The continued execution of the digital transformation strategy and the company's ability to navigate potential weather and geopolitical challenges will be crucial for future growth.
